Alzheimer’s disease can be characterized by three main phases:
(1) Preclinical AD: Abnormal AD biomarkers but no clinical symptoms
(2) MCI (Mild Cognitive Impairment): Individuals are mildly symptomatic but do not have dementia. MCI denotes cognitive decline without impairment in activities of daily living
(3) Dementia: Individuals show progressive loss of cognitive function and the ability to live independently
Read more about the typical course of Alzheimer’s disease
Related content
Drug Delivery Systems to the Brain
Brain drug delivery systems, allied with their characteristics for overcoming the blood-brain barrier (BBB).
29.04.2025
Alzheimer’s Disease
From One-Size-Fits-All to Precision Medicine
The use of a single treatment in heterogeneous populations has proved problematic in clinical trials undertaken in patients with neurodegenerative diseases.
29.04.2025
Alzheimer’s Disease